Drug Type AAV based gene therapy |
Synonyms- |
Target |
Mechanism SANS modulators(USH1 protein network component sans modulators), Gene transference |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Usher Syndromes | Preclinical | FR | - | |
Usher Syndromes | Preclinical | FR | - | |
Usher Syndromes | Preclinical | FR | - | |
Usher Syndromes | Preclinical | FR | - | |
Usher Syndromes | Preclinical | FR | - |